Setsuo Utsunomiya

634 total citations
21 papers, 468 citations indexed

About

Setsuo Utsunomiya is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Setsuo Utsunomiya has authored 21 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Hepatology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Setsuo Utsunomiya's work include Colorectal Cancer Treatments and Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Gastric Cancer Management and Outcomes (8 papers). Setsuo Utsunomiya is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Gastric Cancer Management and Outcomes (8 papers). Setsuo Utsunomiya collaborates with scholars based in Japan. Setsuo Utsunomiya's co-authors include Kohei Shitara, Tomoya Yokota, Kei Muro, Daisuke Takahari, Takashi Ura, Yasushi Yatabe, Chiaki Kondo, Motoo Nomura, Norio Shibata and Ayako Mizota and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and The American Journal of Gastroenterology.

In The Last Decade

Setsuo Utsunomiya

18 papers receiving 457 citations

Peers

Setsuo Utsunomiya
F. P. Rossini Italy
Friedemann Krause Germany
Giorgio Patelli Italy
Apurvasena Parikh United States
Abdullah Esmail United States
Manuel Chaves-Conde Spain
Elaine Tan United States
Yih-Jyh Lin Taiwan
David Casadevall Spain
F. P. Rossini Italy
Setsuo Utsunomiya
Citations per year, relative to Setsuo Utsunomiya Setsuo Utsunomiya (= 1×) peers F. P. Rossini

Countries citing papers authored by Setsuo Utsunomiya

Since Specialization
Citations

This map shows the geographic impact of Setsuo Utsunomiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Setsuo Utsunomiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Setsuo Utsunomiya more than expected).

Fields of papers citing papers by Setsuo Utsunomiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Setsuo Utsunomiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Setsuo Utsunomiya. The network helps show where Setsuo Utsunomiya may publish in the future.

Co-authorship network of co-authors of Setsuo Utsunomiya

This figure shows the co-authorship network connecting the top 25 collaborators of Setsuo Utsunomiya. A scholar is included among the top collaborators of Setsuo Utsunomiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Setsuo Utsunomiya. Setsuo Utsunomiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Utsunomiya, Setsuo, et al.. (2017). A case of liver metastases with hyperbilirubinemia that was safely treated with chemotherapy (FOLFOX plus Cetuximab). Annals of Oncology. 28. ix105–ix105. 2 indexed citations
2.
Yoshioka, Naoki, Akihiko Okumura, Kentaro Yamada, et al.. (2017). Promoting notification and linkage of HBs antigen and anti-HCV antibody-positive patients through hospital alert system. BMC Infectious Diseases. 17(1). 330–330. 8 indexed citations
3.
4.
Utsunomiya, Setsuo. (2013). Synchronous rectal and esophageal cancer treated with chemotherapy followed by two-stage resection. World Journal of Clinical Cases. 1(2). 87–87. 2 indexed citations
5.
Shitara, Kohei, Satoshi Yuki, Michio Nakamura, et al.. (2013). Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer. British Journal of Cancer. 110(2). 271–277. 23 indexed citations
6.
Utsunomiya, Setsuo, et al.. (2012). Efficacy of trastuzumab plus paclitaxel for HER2-positive gastroesophageal junction cancer that is refractory to S-1. International Cancer Conference Journal. 2(2). 116–119.
7.
Shitara, Kohei, Takashi Ura, Keitaro Matsuo, et al.. (2011). Sensitivity to previous irinotecan treatment does not predict the efficacy of combination chemotherapy with cetuximab plus irinotecan for wild-type KRAS metastatic colorectal cancer. European Journal of Cancer. 47(18). 2673–2680. 1 indexed citations
8.
Yokota, Tomoya, Takashi Ura, Norio Shibata, et al.. (2011). BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer. British Journal of Cancer. 104(5). 856–862. 307 indexed citations
9.
Kuzuya, Teiji, Setsuo Utsunomiya, Noboru Kawata, et al.. (2011). [A case of intractable hepatic encephalopathy successfully treated by oral administration of vancomycin hydrochloride, with subsequent improvement of hepatic function reserve enabling transcatheter arterial chemoembolization against hepatocellular carcinoma].. PubMed. 38(6). 995–7. 2 indexed citations
10.
Shitara, Kohei, Tomoya Yokota, Daisuke Takahari, et al.. (2010). Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRAS. Investigational New Drugs. 29(4). 688–693. 13 indexed citations
11.
Shitara, Kohei, Tomoya Yokota, Daisuke Takahari, et al.. (2010). Phase II Study of Combination Chemotherapy with Biweekly Cetuximab and Irinotecan for Pre-treated Metastatic Colorectal Cancer Harboring Wild-type KRAS. Japanese Journal of Clinical Oncology. 40(7). 699–701. 4 indexed citations
12.
Shitara, Kohei, Satoshi Yuki, Motoki Yoshida, et al.. (2010). Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-type KRAS metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines. Investigational New Drugs. 30(2). 787–793. 14 indexed citations
13.
Imai, Norihiro, Teiji Kuzuya, Setsuo Utsunomiya, et al.. (2009). High Incidence of Colonic Perforation During Colonoscopy in Hemodialysis Patients With End-Stage Renal Disease. Clinical Gastroenterology and Hepatology. 8(1). 55–59. 19 indexed citations
14.
Shitara, Kohei, Tomoya Yokota, & Setsuo Utsunomiya. (2009). Cetuximab for patients with colon cancer and hepatic metastasis complicated by liver dysfunction and icterus.. PubMed. 3(4). 171–2. 5 indexed citations
15.
Utsunomiya, Setsuo, Kentaro Yoshioka, Takaji Wakita, et al.. (1999). Tt Virus Infection in Hemodialysis Patients. The American Journal of Gastroenterology. 94(12). 3567–3570. 26 indexed citations
16.
17.
Utsunomiya, Setsuo, et al.. (1999). [The prevalence of TTV infection and the route of TTV transmission in hemodialysis patients--compared with HCV infection].. PubMed. 57(6). 1417–20. 1 indexed citations
18.
Utsunomiya, Setsuo, et al.. (1976). Attempts at Cultivation of Mycobacterium leprae in Cell Cultures. Japanese Journal of Microbiology. 20(5). 471–473.
19.
Tasaka, H, et al.. (1976). A Culturable Mycobacterium Isolated from Leproma of a Leprosy-Transmitted Armadillo. PubMed. 45(2). 63–67. 1 indexed citations
20.
Utsunomiya, Setsuo, et al.. (1956). [Methods for determination of factors stimulating resistance against tuberculosis infection in mice].. PubMed. 113(5). 375–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. P. Rossini Breakdown of academic impact, for papers by Friedemann Krause Breakdown of academic impact, for papers by Giorgio Patelli Breakdown of academic impact, for papers by Apurvasena Parikh Breakdown of academic impact, for papers by Abdullah Esmail Breakdown of academic impact, for papers by Manuel Chaves-Conde Breakdown of academic impact, for papers by Elaine Tan Breakdown of academic impact, for papers by Yih-Jyh Lin Breakdown of academic impact, for papers by David Casadevall
Rankless by CCL
2026